MentionFox
Home › Stakes › 20/20 Biolabs, Inc.
5%+ stakes · Schedule 13D and 13G

20/20 Biolabs, Inc.: 5%+ holders

Who has reported owning 5% or more of 20/20 Biolabs, Inc., from Schedule 13D and 13G filings: each holder's stake as filed, the timeline, and the purpose each 13D states, quoted.

At 5% or more3
Filings3
Latest filing2026-03-10

20/20 Biolabs, Inc. has 3 Schedule 13D or 13G filings on record since 2026-02-25. 3 holders' latest filing reports 5% or more of common stock, par value $0.01. Each figure below is the holder's own, as filed, with the filing linked.

Holders

HolderPercentSharesLatestEvent date
Jonathan M Cohen16.8%1,833,750SCHEDULE 13D, 2026-03-102026-03-03
Streeterville Capital LLC9.9%543,680SCHEDULE 13G, 2026-02-252026-02-25
Full Succeed International Limited6.3%651,465SCHEDULE 13G, 2026-03-102026-02-19

Purpose of Transaction (Item 4)

Jonathan M Cohen

The securities held by the Reporting Person were acquired in connection with the transactions described in Item 3 above. The Reporting Person has made no plans or proposals which would be related to or would result in any of the events or matters described in part (a) through (j) of Item 4 above.Item 4 of the SCHEDULE 13D filed 2026-03-10

Timeline

FiledHolderPercentFiling
2026-02-25Streeterville Capital LLC9.9%SCHEDULE 13G
2026-03-10Jonathan M Cohen16.8%SCHEDULE 13D
2026-03-10Full Succeed International Limited6.3%SCHEDULE 13G

Tools for this story

Each opens in a new tab, filled in for 20/20 Biolabs, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

Cite this page

Permanent URL: https://mentionfox.com/stakes/20-20-biolabs
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3
20/20 Biolabs, Inc. 5%+ holders: 3 at 5% or more, largest Jonathan M Cohen 16.8%. MentionFox, 2026-09-27. https://mentionfox.com/stakes/20-20-biolabs